Development of plasma kallikrein selective inhibitors
โ Scribed by Yoshio Okada; Yuko Tsuda; Mayako Tada; Keiko Wanaka; Akiko Hijikata-Okunomiya; Utako Okamoto; Shosuke Okamoto
- Publisher
- Wiley (John Wiley & Sons)
- Year
- 1999
- Tongue
- English
- Weight
- 340 KB
- Volume
- 51
- Category
- Article
- ISSN
- 0006-3525
No coin nor oath required. For personal study only.
โฆ Synopsis
During the course of the development of active center-directed plasmin inhibitors, it was found that N-(trans-4-aminomethylcyclohexanecarbonyl)-lysine-4-methoxycarbonylanilide inhibited plasma kallikrein more potently than other enzymes such as plasmin, urokinase, and thrombin, although the inhibitory activity was not as potent and enzyme selectivity not as high. Based on studies of structure-activity relationship, we designed and synthesized the plasma kallikrein selective inhibitor, N-(trans-4-aminomethylcyclohexanecarbonyl)-phenylalanine-4-carboxymethyl-
๐ SIMILAR VOLUMES
Rab guanosine triphosphatases (GTPases) are key players in the regulation of eukaryotic intracellular trafficking events such as the formation, motility, targeting, and docking of vesicles. [1] The reversible association of Rab GTPases with intracellular membranes and other proteins is essential for
## Abstract For Abstract see ChemInform Abstract in Full Text.